Introduction: Liver is the most commonly involved organ by metastatic disease. Secondary tumors are more frequent lesion forming more than 75%, while primary cancers of liver formed less than 25%. Imaging according to LI-RAD can give a clue for the nature of the primary lesion of live particularly hepatocellular carcinoma. Liver biopsy is still the golden standard surveillance for histopathological diagnosis of liver tumor; however, it is a traumatic procedure, but its value in reaching the definite diagnosis is superior to imaging technique. Tru cut biopsy is less traumatic than open biopsy and considered nowadays as the preferable technical way in sampling liver tissue that can be applied for both histopathology and immunohistochemistry. Secondary liver lesions were encountered to be originated from lung, breast, Pancreatobiliary tract and GIT, female genital tract, prostate and others. Objectives of the Study: To assess the efficacy of Tru cut biopsy for both histopathological examination and immunohistochemical study identification the type and origin of liver tumors. Methodology: This is a cross sectional study conducted in the Al-Sadr Teaching Hospital in Al-Najaf City, Iraq from January 2019 till December 2021.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.